Search Here

Daily dose of Aspirin can help men cut down risk prostate cancer and reduce risks of dying from aggressive forms of the disease, a new study has shown.

According to Yahoo News the findings of the study were presented at the 13^th American Association for Cancer Research conference on Tuesday. Researchers at Duke University of Medicine who reported the findings said that men who regularly used Aspirin or similar anti-inflammatory medication had a 13 percent lower risk of disease onset besides a 17 percent improvement in odds against aggressive tumors.  

The four-year study involved 6,930 men who did not have prostate cancer before the start of the study. Half of them were given aspirin or similar non-steroidal anti-inflammatory drug while the other half did not receive any medication. At the end of the study men who take medication had lowered risks.

However the study does not recommend daily intake just yet as the authors have called for more research given that aspirin can cause side-effects like intestinal bleeding.  

Aspirin's role in reducing risk of heart attacks is well-established. It is also known that daily dose of aspirin can reduced risks of colon and breast cancer. A separate study recently helped understood the mechanism behind Aspirin lowering prostate cancer risk, Tech Times reported.

"We found the mechanism to explain how low-dose aspirin can eventually decrease the incidence of new cancers after you have taken it for five years or more. It can also explain why people who are taking aspirin after being diagnosed have a lower risk of dying of their metastases," said Pierre Massion, of Vanderbilt University School of Medicine in Nashville who was part of a second study which determined aspirin's role in controlling prostate cancer.

Reporting on Massion's study, Bloomberg pointed out that aspirin inhibits production of Cox-2 an enzyme associated with pain and inflammation. Cox-2 production is associated with increased levels of prostaglandin E2 production which in turn is associated with cancer spread.